Will GoodRX Stock Bounce Back?
GoodRX (NASDAQ:GDRX) tracks prescription drug prices and its model was…
Sell
31
IVA Quote, Financials, Valuation and Earnings
Last price:
$3.27
Seasonality move
:
-16.04%
Day range:
$3.22 - $3.40
52-week range:
$1.53 - $4.05
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
20.24x
P/B ratio:
--
Volume:
6.2K
Avg. volume:
24.9K
1-year change:
27.69%
Market cap:
$317.6M
Revenue:
$10M
EPS (TTM):
-$2.22
| Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
|---|---|---|---|---|---|---|
| Revenue | $424.8K | $5M | $12.8M | $18.9M | $10M | |
| Revenue Growth (YoY) | -94.58% | 1068.05% | 158.83% | 47.31% | -47.38% | |
| Cost of Revenues | -- | -- | -- | -- | -- | |
| Gross Profit | -- | -- | -- | -- | -- | |
| Gross Profit Margin | -- | -- | -- | -- | -- | |
| R&D Expenses | $27.1M | $57.3M | $63.8M | $119.1M | $98.4M | |
| Selling, General & Admin | $10.1M | $13.4M | $16.1M | $16.9M | $18.5M | |
| Other Inc / (Exp) | -$8.3M | $2.3M | $3.1M | -$3.2M | -$85.3M | |
| Operating Expenses | $30.7M | $65.5M | $72.8M | $130.1M | $111.7M | |
| Operating Income | -$30.3M | -$60.5M | -$60M | -$111.1M | -$101.7M | |
| Net Interest Expenses | -- | $101.8K | $383.9K | $4.6M | $12M | |
| EBT. Incl. Unusual Items | -$38.4M | -$58.3M | -$57.3M | -$118.9M | -$199M | |
| Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
| Income Tax Expense | -- | $430.7K | -$21.1K | $657.1K | $338.8K | |
| Net Income to Company | -$38.4M | -$58.7M | -$57.2M | -$119.5M | -$199.4M | |
| Minority Interest in Earnings | -- | -- | -- | -- | -- | |
| Net Income to Common Excl Extra Items | -$38.4M | -$58.7M | -$57.2M | -$119.5M | -$199.4M | |
| Basic EPS (Cont. Ops) | -$1.13 | -$1.50 | -$1.38 | -$2.63 | -$3.33 | |
| Diluted EPS (Cont. Ops) | -$1.13 | -$1.50 | -$1.38 | -$2.63 | -$3.33 | |
| Weighted Average Basic Share | $33.9M | $39.2M | $41.4M | $45.4M | $59.8M | |
| Weighted Average Diluted Share | $33.9M | $39.2M | $41.4M | $45.4M | $59.8M | |
| EBITDA | -$36.2M | -$57.9M | -$54.7M | -$110.5M | -$180.2M | |
| EBIT | -$38.3M | -$58.1M | -$56.5M | -$113.3M | -$185.9M | |
| Revenue (Reported) | $424.8K | $5M | $12.8M | $18.9M | $10M | |
| Operating Income (Reported) | -$30.3M | -$60.5M | -$60M | -$111.1M | -$101.7M | |
| Operating Income (Adjusted) | -$38.3M | -$58.1M | -$56.5M | -$113.3M | -$185.9M | |
| Period Ending | 2017-06-30 | 2018-06-30 | 2019-06-30 | 2020-06-30 | 2021-06-30 | |
|---|---|---|---|---|---|---|
| Revenue | -- | -- | -- | $81.5K | $78.3K | |
| Revenue Growth (YoY) | -- | -- | -- | -- | -- | |
| Cost of Revenues | -- | -- | -- | -- | -- | |
| Gross Profit | -- | -- | -- | -- | -- | |
| Gross Profit Margin | -- | -- | -- | -- | -- | |
| R&D Expenses | -- | -- | -- | $7.2M | $14.4M | |
| Selling, General & Admin | -- | -- | -- | $2M | $3.8M | |
| Other Inc / (Exp) | -- | -- | -- | $5.5K | -$709.9K | |
| Operating Expenses | -- | -- | -- | $9.8M | $16.6M | |
| Operating Income | -- | -- | -- | -$9.8M | -$16.5M | |
| Net Interest Expenses | -- | -- | -- | -- | -- | |
| EBT. Incl. Unusual Items | -- | -- | -- | -$9.8M | -$17.2M | |
| Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
| Income Tax Expense | -- | -- | -- | -- | $25.3K | |
| Net Income to Company | -- | -- | -- | -$9.7M | -$17.2M | |
| Minority Interest in Earnings | -- | -- | -- | -- | -- | |
| Net Income to Common Excl Extra Items | -- | -- | -- | -$9.8M | -$17.2M | |
| Basic EPS (Cont. Ops) | -- | -- | -- | -$0.25 | -$0.45 | |
| Diluted EPS (Cont. Ops) | -- | -- | -- | -$0.25 | -$0.45 | |
| Weighted Average Basic Share | -- | -- | -- | $38.7M | $38.7M | |
| Weighted Average Diluted Share | -- | -- | -- | $38.7M | $38.7M | |
| EBITDA | -- | -- | -- | -$9.4M | -$16.9M | |
| EBIT | -- | -- | -- | -$9.7M | -$17.2M | |
| Revenue (Reported) | -- | -- | -- | $81.5K | $78.3K | |
| Operating Income (Reported) | -- | -- | -- | -$9.8M | -$16.5M | |
| Operating Income (Adjusted) | -- | -- | -- | -$9.7M | -$17.2M | |
| Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
|---|---|---|---|---|---|---|
| Revenue | $6.5M | -- | $12.5M | $18.8M | $9.8M | |
| Revenue Growth (YoY) | -- | -- | -- | -- | -- | |
| Cost of Revenues | -- | -- | -- | -- | -- | |
| Gross Profit | -- | -- | -- | -- | -- | |
| Gross Profit Margin | -- | -- | -- | -- | -- | |
| R&D Expenses | -- | -- | $63.1M | $119.2M | $97.4M | |
| Selling, General & Admin | -- | -- | $15.9M | $16.9M | $18.3M | |
| Other Inc / (Exp) | -- | -- | $3.2M | -$3.1M | -$84M | |
| Operating Expenses | -- | -- | $72M | $130.2M | $110.6M | |
| Operating Income | -- | -- | -$59.6M | -$111.3M | -$100.8M | |
| Net Interest Expenses | -- | -- | $376.8K | $4.6M | $11.9M | |
| EBT. Incl. Unusual Items | -- | -- | -$56.8M | -$119M | -$196.6M | |
| Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
| Income Tax Expense | -- | -- | -$21.3K | $653.6K | $334.9K | |
| Net Income to Company | -- | -- | -$56.8M | -$119.7M | -$196.9M | |
| Minority Interest in Earnings | -- | -- | -- | -- | -- | |
| Net Income to Common Excl Extra Items | -- | -- | -$56.8M | -$119.7M | -$196.9M | |
| Basic EPS (Cont. Ops) | -- | -- | -$1.37 | -$2.63 | -$3.29 | |
| Diluted EPS (Cont. Ops) | -- | -- | -$1.37 | -$2.63 | -$3.29 | |
| Weighted Average Basic Share | ||||||
| Weighted Average Diluted Share | ||||||
| EBITDA | -- | -- | -$54.3M | -$110.6M | -$178M | |
| EBIT | -- | -- | -$56M | -$113.4M | -$183.5M | |
| Revenue (Reported) | $6.5M | -- | $12.5M | $18.8M | $9.8M | |
| Operating Income (Reported) | -- | -- | -$59.6M | -$111.3M | -$100.8M | |
| Operating Income (Adjusted) | -- | -- | -$56M | -$113.4M | -$183.5M | |
| Period Ending | 2021-07-17 | 2022-07-17 | 2023-07-17 | 2024-07-17 | ||
|---|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- | |
| Revenue Growth (YoY) | -- | -- | -- | -- | -- | |
| Cost of Revenues | -- | -- | -- | -- | -- | |
| Gross Profit | -- | -- | -- | -- | -- | |
| Gross Profit Margin | -- | -- | -- | -- | -- | |
| R&D Expenses | -- | -- | -- | -- | -- | |
| Selling, General & Admin | -- | -- | -- | -- | -- | |
| Other Inc / (Exp) | -- | -- | -- | -- | -- | |
| Operating Expenses | -- | -- | -- | -- | -- | |
| Operating Income | -- | -- | -- | -- | -- | |
| Net Interest Expenses | -- | -- | -- | -- | -- | |
| EBT. Incl. Unusual Items | -- | -- | -- | -- | -- | |
| Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
| Income Tax Expense | -- | -- | -- | -- | -- | |
| Net Income to Company | -- | -- | -- | -- | -- | |
| Minority Interest in Earnings | -- | -- | -- | -- | -- | |
| Net Income to Common Excl Extra Items | -- | -- | -- | -- | -- | |
| Basic EPS (Cont. Ops) | -- | -- | -- | -- | -- | |
| Diluted EPS (Cont. Ops) | -- | -- | -- | -- | -- | |
| Weighted Average Basic Share | -- | -- | -- | -- | -- | |
| Weighted Average Diluted Share | -- | -- | -- | -- | -- | |
| EBITDA | -- | -- | -- | -- | -- | |
| EBIT | -- | -- | -- | -- | -- | |
| Revenue (Reported) | -- | -- | -- | -- | -- | |
| Operating Income (Reported) | -- | -- | -- | -- | -- | |
| Operating Income (Adjusted) | -- | -- | -- | -- | -- | |
| Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
|---|---|---|---|---|---|---|
| Cash and Equivalents | $130M | $98M | $93M | $29.8M | $100.5M | |
| Short Term Investments | $9M | $10M | $1.1M | $77.4K | -- | |
| Accounts Receivable, Net | $59K | $4.5M | -- | $4.2M | $552.5K | |
| Inventory | $393.6K | $443.8K | $400K | $461K | -- | |
| Prepaid Expenses | $4.1M | $8.4M | $9.2M | $5.1M | $2.5M | |
| Other Current Assets | $1.3M | $863.9K | $302.4K | $466.5K | $363.2K | |
| Total Current Assets | $163.6M | $130.9M | $114.1M | $53.3M | $116M | |
| Property Plant And Equipment | $4M | $3.6M | $7.9M | $10.1M | $5.2M | |
| Long-Term Investments | $2.1M | -- | -- | $1.6M | $1.2M | |
| Goodwill | -- | -- | -- | -- | -- | |
| Other Intangibles | $1.2M | $871.8K | $609.1K | $599.1K | $50K | |
| Other Long-Term Assets | -- | -- | -- | -- | -- | |
| Total Assets | $170.9M | $138.1M | $124.4M | $76.9M | $123.8M | |
| Accounts Payable | $8.5M | $16.5M | $20.8M | $41.7M | $34.2M | |
| Accrued Expenses | $1.7M | $1.4M | $1.4M | $1.7M | $1.8M | |
| Current Portion Of Long-Term Debt | $19.7K | $1.4M | $4.9M | $3.3M | $3.5M | |
| Current Portion Of Capital Lease Obligations | $2.5K | $43K | $1.4M | $2.5M | $2.6M | |
| Other Current Liabilities | -- | $1.1K | -$1.1K | -- | $76.4M | |
| Total Current Liabilities | $17.1M | $25.9M | $32.9M | $55.4M | $125.6M | |
| Long-Term Debt | $12.3M | $9.9M | $27.3M | $30.9M | $48.2M | |
| Capital Leases | -- | -- | -- | -- | -- | |
| Total Liabilities | $34.1M | $37.5M | $75.6M | $112.3M | $234.8M | |
| Common Stock | $474.8K | $463.1K | $451.5K | $575.9K | $995.8K | |
| Other Common Equity Adj | $5.9M | -$30.4M | -$79.7M | -$137.7M | -$180.2M | |
| Common Equity | $136.8M | $100.6M | $48.8M | -$35.4M | -$111M | |
| Total Preferred Equity | -- | -- | -- | -- | -- | |
| Minority Interest, Total | -- | -- | -- | -- | -- | |
| Total Equity | $136.8M | $100.6M | $48.8M | -$35.4M | -$111M | |
| Total Liabilities and Equity | $170.9M | $138.1M | $124.4M | $76.9M | $123.8M | |
| Cash and Short Terms | $139M | $108M | $94.1M | $29.8M | $100.5M | |
| Total Debt | $12.4M | $11.3M | $32.2M | $34.2M | $51.7M | |
| Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
|---|---|---|---|---|---|---|
| Cash and Equivalents | -- | -- | $93M | $29.8M | $100.5M | |
| Short Term Investments | -- | -- | $1.1M | $77.4K | -- | |
| Accounts Receivable, Net | -- | -- | -- | $4.2M | $552.5K | |
| Inventory | -- | -- | $400K | $461K | -- | |
| Prepaid Expenses | -- | -- | $9.2M | $5.1M | $2.5M | |
| Other Current Assets | -- | -- | $302.4K | $466.5K | $363.2K | |
| Total Current Assets | -- | -- | $114.1M | $53.3M | $116M | |
| Property Plant And Equipment | -- | -- | $7.9M | $10.1M | $5.2M | |
| Long-Term Investments | -- | -- | -- | $1.6M | $1.2M | |
| Goodwill | -- | -- | -- | -- | -- | |
| Other Intangibles | -- | -- | $609.1K | $599.1K | $50K | |
| Other Long-Term Assets | -- | -- | -- | -- | -- | |
| Total Assets | -- | -- | $124.4M | $76.9M | $123.8M | |
| Accounts Payable | -- | -- | $20.8M | $41.7M | $34.2M | |
| Accrued Expenses | -- | -- | $1.4M | $1.7M | $1.8M | |
| Current Portion Of Long-Term Debt | -- | -- | $4.9M | $3.3M | $3.5M | |
| Current Portion Of Capital Lease Obligations | -- | -- | $1.4M | $2.5M | $2.6M | |
| Other Current Liabilities | -- | -- | -$1.1K | -- | $76.4M | |
| Total Current Liabilities | -- | -- | $32.9M | $55.4M | $125.6M | |
| Long-Term Debt | -- | -- | $27.3M | $30.9M | $48.2M | |
| Capital Leases | -- | -- | -- | -- | -- | |
| Total Liabilities | -- | -- | $75.6M | $112.3M | $234.8M | |
| Common Stock | -- | -- | $451.5K | $575.9K | $995.8K | |
| Other Common Equity Adj | -- | -- | -$79.7M | -$137.7M | -$180.2M | |
| Common Equity | -- | -- | -- | -- | -- | |
| Total Preferred Equity | -- | -- | -- | -- | -- | |
| Minority Interest, Total | -- | -- | -- | -- | -- | |
| Total Equity | -- | -- | $48.8M | -$35.4M | -$111M | |
| Total Liabilities and Equity | -- | -- | $124.4M | $76.9M | $123.8M | |
| Cash and Short Terms | $130M | -- | $94.1M | $29.8M | $100.5M | |
| Total Debt | -- | -- | $32.2M | $34.2M | $51.7M | |
| Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | -$38.4M | -$58.7M | -$57.2M | -$119.5M | -$199.4M | |
| Depreciation & Amoritzation | $2.2M | -$1.5M | $1.8M | $2.8M | $5.6M | |
| Stock-Based Compensation | $1.1M | $2.5M | $2.3M | $4.3M | $3.9M | |
| Change in Accounts Receivable | -$524.2K | -$6.3M | $4.1M | -$6.3M | $3M | |
| Change in Inventories | $77.7K | -$85.2K | $20K | -$47.6K | $451.3K | |
| Cash From Operations | -$34.9M | -$56.4M | -$47.4M | -$88.4M | -$93M | |
| Capital Expenditures | $333.5K | $631.8K | $591.6K | $584.6K | $360.4K | |
| Cash Acquisitions | -- | -- | -- | -- | -- | |
| Cash From Investing | -$9.8M | -$2.1M | $9.4M | -$8.4M | $9.5M | |
| Dividends Paid (Ex Special Dividend) | -- | -- | -- | -- | -- | |
| Special Dividend Paid | ||||||
| Long-Term Debt Issued | -- | -- | $31.9M | -- | $27M | |
| Long-Term Debt Repaid | -$99.4K | -$33.1K | -$1.9M | -$4.4M | -$5.4M | |
| Repurchase of Common Stock | -- | -- | -- | -- | -- | |
| Other Financing Activities | $11.4M | -- | -- | $2.8M | $10.9M | |
| Cash From Financing | $127.5M | $30.1M | $39.3M | $31.5M | $157.6M | |
| Beginning Cash (CF) | $40.9M | $125M | $91.3M | $93.9M | $29.1M | |
| Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
| Additions / Reductions | $82.8M | -$28.4M | $1.3M | -$65.2M | $74M | |
| Ending Cash (CF) | $120.7M | $102.4M | $91.5M | $29.1M | $104.5M | |
| Levered Free Cash Flow | -$35.3M | -$57M | -$48M | -$88.9M | -$93.4M | |
| Period Ending | 2017-06-30 | 2018-06-30 | 2019-06-30 | 2020-06-30 | 2021-06-30 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | -- | -- | -- | -$9.7M | -$17.2M | |
| Depreciation & Amoritzation | -- | -- | -- | $362.7K | $277.2K | |
| Stock-Based Compensation | -- | -- | -- | $343.1K | $731.6K | |
| Change in Accounts Receivable | -- | -- | -- | -$296K | $95.2K | |
| Change in Inventories | -- | -- | -- | $30.8K | -$71.1K | |
| Cash From Operations | -- | -- | -- | -$3.9M | -$14.5M | |
| Capital Expenditures | -- | -- | -- | -- | -- | |
| Cash Acquisitions | -- | -- | -- | -- | -- | |
| Cash From Investing | -- | -- | -- | -$1.1M | -$2M | |
| Dividends Paid (Ex Special Dividend) | -- | -- | -- | -- | -- | |
| Special Dividend Paid | -- | -- | -- | -- | -- | |
| Long-Term Debt Issued | -- | -- | -- | $11M | -- | |
| Long-Term Debt Repaid | -- | -- | -- | -$19.7K | -$1.2K | |
| Repurchase of Common Stock | -- | -- | -- | -- | -- | |
| Other Financing Activities | -- | -- | -- | -$1.1K | -$1.2K | |
| Cash From Financing | -- | -- | -- | $11M | $56.6K | |
| Beginning Cash (CF) | -- | -- | -- | $51.7M | $129.9M | |
| Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -$693.6K | |
| Additions / Reductions | -- | -- | -- | $5.9M | -$16.4M | |
| Ending Cash (CF) | -- | -- | -- | $57.6M | $112.8M | |
| Levered Free Cash Flow | -- | -- | -- | -- | -- | |
| Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | -- | -- | -$56.8M | -$119.7M | -$196.9M | |
| Depreciation & Amoritzation | -- | -- | $1.8M | $2.8M | $5.6M | |
| Stock-Based Compensation | -- | -- | $2.3M | $4.3M | $3.8M | |
| Change in Accounts Receivable | -- | -- | $4.1M | -$6.3M | $3M | |
| Change in Inventories | -- | -- | $21K | -$47.8K | $444.8K | |
| Cash From Operations | -$35.8M | -- | -$47.1M | -$88.5M | -$92.1M | |
| Capital Expenditures | -- | -- | $586.3K | $584.6K | $357.7K | |
| Cash Acquisitions | -- | -- | -- | -- | -- | |
| Cash From Investing | -- | -- | $9.1M | -$8.4M | $9.4M | |
| Dividends Paid (Ex Special Dividend) | -- | -- | -- | -- | -- | |
| Special Dividend Paid | ||||||
| Long-Term Debt Issued | -- | -- | $31.1M | -- | $26.8M | |
| Long-Term Debt Repaid | -- | -- | -$1.8M | -$4.4M | -$5.3M | |
| Repurchase of Common Stock | -- | -- | -- | -- | -- | |
| Other Financing Activities | -- | -- | -- | -- | $10.8M | |
| Cash From Financing | -- | -- | $38.7M | $31.3M | $155.4M | |
| Beginning Cash (CF) | -- | -- | -- | -- | -- | |
| Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
| Additions / Reductions | -- | -- | -$2.8M | -$64.7M | $74M | |
| Ending Cash (CF) | -- | -- | -- | -- | -- | |
| Levered Free Cash Flow | -- | -- | -$47.6M | -$89.1M | -$92.5M | |
| Period Ending | 2021-07-17 | 2022-07-17 | 2023-07-17 | 2024-07-17 | ||
|---|---|---|---|---|---|---|
| Net Income to Stockholders | -- | -- | -- | -- | -- | |
| Depreciation & Amoritzation | -- | -- | -- | -- | -- | |
| Stock-Based Compensation | -- | -- | -- | -- | -- | |
| Change in Accounts Receivable | -- | -- | -- | -- | -- | |
| Change in Inventories | -- | -- | -- | -- | -- | |
| Cash From Operations | -- | -- | -- | -- | -- | |
| Capital Expenditures | -- | -- | -- | -- | -- | |
| Cash Acquisitions | -- | -- | -- | -- | -- | |
| Cash From Investing | -- | -- | -- | -- | -- | |
| Dividends Paid (Ex Special Dividend) | -- | -- | -- | -- | -- | |
| Special Dividend Paid | -- | -- | -- | -- | -- | |
| Long-Term Debt Issued | -- | -- | -- | -- | -- | |
| Long-Term Debt Repaid | -- | -- | -- | -- | -- | |
| Repurchase of Common Stock | -- | -- | -- | -- | -- | |
| Other Financing Activities | -- | -- | -- | -- | -- | |
| Cash From Financing | -- | -- | -- | -- | -- | |
| Beginning Cash (CF) | -- | -- | -- | -- | -- | |
| Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
| Additions / Reductions | -- | -- | -- | -- | -- | |
| Ending Cash (CF) | -- | -- | -- | -- | -- | |
| Levered Free Cash Flow | -- | -- | -- | -- | -- | |
Get IVA Stock Alert
Signup to receive the latest stock alerts
Financial Ratios
IVA
Sector
P/E ratio
--
23.88x
PEG ratio
-0.01x
0.00x
P/B ratio
--
1.80x
Price / LTM sales
20.24x
1.65x
Growth Metrics
IVA
Sector
Revenue growth
--
4.06%
Earnings growth
--
7.46%
Revenue (5-year growth)
4.91%
8.01%
Earnings forecast
-$0.48
-$0.20
Profitability
IVA
Sector
Profitability FY 2025
--
$47.5M
Return on invested capital
--
-16.26%
Return on assets
-171.62%
-13.27%
Return on equity
--
-18.61%
Earnings Date
Last Earnings Date
Mar
26
Next Earnings Date
Sep
25
Estimated Next Earnings Date
Jun
25
Balance Sheet
IVA
Sector
Total cash
$10.9M
$35.5M
Short term investments
--
$29.7M
Total assets
$123.8M
$106.9M
Long term debt
$50.2M
$7.1M
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Will FCX Benefit From Tariffs?
Freeport-McMoRan (NYSE:FCX) is among the world’s largest producers of copper…
Can Levi Stock Double?
Levi Strauss (NYSE:LEVI) is among the oldest clothing brands in…
Stock Ideas
Buy
70
Is NVDA Stock a Buy?
Market Cap: $4.2T
P/E Ratio: 58x
Buy
62
Is MSFT Stock a Buy?
Market Cap: $3.8T
P/E Ratio: 43x
Sell
40
Is AAPL Stock a Buy?
Market Cap: $3.1T
P/E Ratio: 35x
Alerts
Buy
82
SBET alert for Jul 17
SharpLink Gaming [SBET] is down 2.6% over the past day.
Buy
89
EXOD alert for Jul 17
Exodus Movement [EXOD] is down 4.14% over the past day.
Buy
60
U alert for Jul 17
Unity Software [U] is up 7.51% over the past day.
THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS
Show me the best stock
